Related Articles
A drug targeting 5‑lipoxygenase enhances the activity of a JAK2 inhibitor in CD34<sup>+</sup> bone marrow cells from patients with JAK2V617F‑positive polycythemia vera <em>in vitro</em>
Prevalence of the Janus kinase 2 V617F mutation in Philadelphia‑negative myeloproliferative neoplasms in a Portuguese population
Determination of prognosis of Philadelphia chromosome‑negative myeloproliferative neoplasms with a simple clinical examination: Retrospective analysis of 71 patients in a single institution
Co‑existence of triple‑negative essential thrombocythemia and double transcript chronic myeloid leukemia: A case report
Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR/ABL1‑negative myeloproliferative neoplasms